Emerson (EMR) Q3 2026: Strong Earnings Growth and Increased Guidance — Positive Outlook

Emerson (NYSE: EMR) reported its third quarter results for the fiscal year 2026, showcasing a robust performance that exceeded expectations. The company achieved net sales of $4,873 million, reflecting an increase of $320 million or +7% compared to $4,553 million in Q3 2025. This growth is indicative of strong demand across its segments, particularly in Software & Systems and broad-based growth in North America and Asia.

Key Financial Metrics

• Net Sales: $4,873 million (up $320 million or +7% YoY)
• Pretax Earnings: $916 million (up $182 million or +24.8% YoY)
• GAAP Earnings Per Share (EPS): $1.28 (up $0.25 or +24% YoY)
• Adjusted EPS: $1.71 (up $0.19 or +13% YoY)
• Operating Cash Flow: $1,425 million (up $363 million or +34% YoY)
• Free Cash Flow: $1,323 million (up $353 million or +36% YoY)

Analyst View

This quarter is undoubtedly a positive outcome for shareholders. The significant growth in both net sales and earnings, coupled with strong cash flow generation, demonstrates Emerson's operational efficiency and ability to capitalize on market demand. The increase in margins—GAAP margin improved to 18.8% from 16.1% (up 270 bps)—further underscores the company's effective cost management and pricing strategies.

Moreover, Emerson's management has raised its full-year guidance, reflecting confidence in sustained demand and operational performance. The updated outlook anticipates net sales growth of approximately 5% for Q4 2026 and an adjusted EPS of around $6.55 for the full year, up from previous estimates.

Shareholder Returns

Emerson declared a quarterly cash dividend of $0.555 per share, payable on September 10, 2026, to stockholders of record on August 14, 2026. This commitment to returning cash to shareholders, alongside plans for approximately $1 billion in share repurchases and $1.2 billion in dividends for the fiscal year, reflects a strong capital allocation strategy.

Forward Catalysts

Investors should closely monitor Emerson's performance in the upcoming quarter, particularly how it navigates potential geopolitical challenges and market fluctuations. The company’s ability to maintain its growth trajectory in a dynamic environment will be crucial. Additionally, updates on the execution of its share repurchase program and any further adjustments to guidance will be key indicators of management's confidence and operational health.

In conclusion, Emerson's Q3 2026 results highlight a strong operational performance and a positive outlook for the remainder of the fiscal year. The combination of increased sales, earnings growth, and shareholder returns positions Emerson favorably in the market, making it an attractive prospect for investors looking for stability and growth.

Note: All amounts are in millions.

	2025 Q3	2026 Q3	Change
Net Sales	$4,553	$4,873	7%
Cost of sales	$2,160	$2,218
SG&A expenses	$1,266	$1,343
Other deductions, net	$298	$311
Interest expense, net	$95	$85
Earnings from continuing operations before income taxes	$734	$916
Income taxes	$154	$198
Earnings from continuing operations	$580	$718
Discontinued operations, net of tax	—	0
Net earnings	$586	$718
Less: Noncontrolling interests in subsidiaries	$7	$8
Net earnings attributable to common stockholders	$734	$916
Earnings per common share	$1.03	$1.28	24%

Note: All amounts are in millions.

Assets	Sept 30, 2025	June 30, 2026
Cash and equivalents	$1,544	$2,180
Receivables, net	$3,101	$3,057
Inventories	$2,213	$2,513
Other current assets	$1,725	$1,905
Total current assets	$8,583	$9,655
Property, plant & equipment, net	$2,871	$2,861
Goodwill	$18,193	$18,122
Other intangible assets	$9,458	$8,686
Other	$2,859	$2,884
Total assets	$41,964	$42,208
Liabilities and equity
Short-term borrowings and current maturities of long-term debt	$4,797	$5,587
Accounts payable	$1,384	$1,613
Accrued expenses	$3,616	$3,572
Total current liabilities	$9,797	$10,772
Long-term debt	$8,319	$7,526
Other liabilities	$3,550	$3,516
Equity
Common stockholders' equity	$20,282	$20,379
Noncontrolling interests in subsidiaries	$16	$15
Total equity	$20,298	$20,394
Total liabilities and equity	$41,964	$42,208

Disclaimer

The content on MarketsFN.com is provided for educational and informational purposes only. It does not constitute financial advice, investment recommendations, or trading guidance. All investments carry risk and past performance does not guarantee future results. You are solely responsible for your investment decisions and should conduct independent research and consult a qualified financial advisor before acting. MarketsFN.com and its authors are not liable for any losses or damages arising from the use of this information.